The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 599-605

  Pitard, Vincent ^a   Lorgeot, Valérie ^b   Taupin, Jean Luc ^a   Aubard, Yves ^c   Praloran, Vincent ^b   Moreau, Jean François ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Blood; Cytokine receptor; Cytokines; Human; Reproductive immunology

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; RECEPTOR SUBUNIT;

ADULT; AMENORRHEA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DELIVERY; EMBRYO DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HUMAN; HUMAN EXPERIMENT; IMMUNOPRECIPITATION; LIVER; NORMAL HUMAN; OLIGOMERIZATION; PLACENTA; PLACENTA FUNCTION; PREGNANCY; SIGNAL TRANSDUCTION; UTERUS; WESTERN BLOTTING;

ADULT; ANIMALS; CELL LINE; FEMALE; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LIVER; LYMPHOKINES; MICE; ONCOSTATIN M; PEPTIDES; PLACENTA; PREGNANCY; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF; RNA; SOLUBILITY; UTERUS;

MURINAE;

EID: 0032410160     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Stewart C L, Kaspar P, Brunet L J, Bhatt H, Gadi I, Köntgen F, Abbondanzo S J. 1992. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359: 76.
2. Shen M M, Leder P. 1992. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc. Natl. Acad. Sci. USA 89: 8240.
3. Bhatt H, Brunet L J, Stewart C L. 1991. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc. Natl. Acad. Sci. USA 88: 11408.
4. Conquet F, Brulet P. 1990. Developmental expression of myeloid leukemia inhibitory factor gene in preimplantation blastocysts and in extraembryonic tissue of mouse embryos. Mol. Cell. Biol. 10: 3801.
5. Rathjen P D, Nichols J, Toth S, Edwards D R, Heath J K, Smith A G. 1990. Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev: 4: 2308.
6. Ware C B, Horowitz M C, Renshaw B R, Hunt J S, Ligitt D, Koblar S A, Gliniak B C, McKenna H J, Papayanopoulou T, Thoma B, Cheng L, Donovan P J, Peschon J J, Bartlett P F, Willis C R, Wright B D, Carpenter M K, Davison B L, Gearing D. 1995. Targeted disruption of the low affinity LIF receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121: 1283.
7. Charnock-Jones D S, Sharkey A M, Fenwick P, Smith S K, 1994. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J. Reprod. Fertil. 101: 421.
8. Delage G, Moreau J F, Taupin J L, Freitas S, Hambartsoumian E, Olivennes F, Fanchin R, Letur-Könirsch H, Frydman R, Chaouat G. 1995. In vitro endometrial secretion of human interleukin for DA cells/leukemia inhibitory factor by explant cultures from fertile and infertile women. Hum. Reprod. 10: 2483.
9. Cullinan E B, Abbondanzo S J, Anderson P S, Pollard J W, Lessey B A, Stewart C L. 1996. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc. Natl. Acad. Sci. USA 93: 3115.
10. Sawai K, Matsuzaki N, Okada T, Shimoya K, Koyama M, Azuma C, Saji F, Murata Y. 1997. Human decidual cell biosynthesis of leukemia inhibitory factor: regulation by decidual cytokines and steroid hormones. Biol. Reprod. 56: 1274.
11. Kojima K, Kankazi H, Iwai M, Hatayama H, Fujimoto M, Inoue T, Horie K, Nakayama H, Fujita J, Mori T. 1997. Expression of leukemia inhibitory factor in human endometrium and placenta. Biol. Reprod. 50: 882.
12. Sawai K, Azuma C, Koyama M, Ito S, Hashimoto K, Kimura T, Samejima Y, Nobunaga T, Saji F. 1995. Leukemia inhibitory factor (LIF) enhances trophoblast differentiation mediated by human chorionic gonadotropin (hCG). Biochem. Biophys. Res. Commun. 211: 137.
13. Stefana B, Ray D W, Melmed S. 1996. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch. Proc. Natl. Acad. Sci. USA 93: 12502.
14. Akita S, Malkin J, Melmed S. 1996. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology 137: 3140.
15. Akita S, Conn P, Melmed S. 1996. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function. J. Clin. Endocrinol. Metab. 81: 4170.
16. Ray D W, Ren S, Melmed S. 1996. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J. Clin. Invest. 97: 1852.
17. Wang Z, Ren S G, Melmed S. 1996. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 137: 2947.
18. Shimon I, Yan X, Ray D W, Melmed S. 1997. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J. Clin. Invest. 100: 357.
19. Hilton D J, Nicola N A. 1992. Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution. J. Biol. Chem. 267: 10238.
20. Layton M J, Cross B A, Metcalf D, Ward L D, Simpson R J, Nicola N A. 1992. A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. Proc. Natl. Acad. Sci. USA 89: 8616.
21. Owczarek C M, Layton M J, Robb L G, Nicola N A, Begley C G. 1996. Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor alpha-chain. Expression in normal, gestating, and leukemia inhibitory factor nullizygous mice. J. Biol. Chem. 271: 5495.
22. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M. 1993. Pregnancy associated increase in mRNA for soluble D-factor/LIF receptor in mouse liver. FEBS Lett. 334: 193.
23. Tomida M. 1995. Analysis of recombinant soluble mouse D-factor/LIF receptor. J. Biochem. 117: 1228.
24. Mereau A, Grey L, Piquet-Pellorce C, Heath J K. 1993. Characterization of a binding protein for leukemia inhibitory factor localized in extracellular matrix. J. Cell Biol. 122: 713.
25. Pitard V, Taupin J L, Miossec V, Blanchard F, Cransac M, Jollet I, Vernallis A, Hudson K, Godard A, Jacques Y, Moreau J F. 1997. Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190. J. Immunol. Methods 205: 177.
26. Fixe P, Lorgeot V, Le Meur Y, Coupey L, Heymann D, Godard A, Praloran V. 1996. Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody. Cytokine 8: 586.
27. Taupin J L, Acres B, Dott K, Schmitt D, Kieny M P, Gualde N, Moreau J F. 1993. Immunogenicity of HILDA/LIF either in a soluble or in a membrane-anchored form expressed in vivo by recombinant vaccinia viruses. Scand. J. Immunol. 38: 293.
28. Tomida M. 1997. Presence of mRNAs encoding the soluble D-factor/LIF receptor in human choriocarcinoma cells and production of the soluble receptor. Biochem. Biophys. Res. Commun. 232: 427.
29. Godard A, Heymann D, Raher S, Anegon I, Peyrat M A, Le Mauff B, Mouray E, Gregoire M, Virdee K, Soulillou J P, Moreau J F, Jacques Y. 1992. High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. J. Biol. Chem. 267: 3214.
30. Yamaguchi-Yamamoto Y, Tomida M, Hozumi M. 1993. Pregnancy associated increase in differentiation-stimulating factor (D-factor)/leukemia inhibitory factor (LIF)-binding substance(s) in mouse serum. Leuk. Res. 17: 515.
31. Gearing D P, Thut C J, van de Bos T, Gimpel S D, Delaney P B, King J, Price V, Cosman D, Beckmann M P. 1991. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 10: 2839.
32. Müllberg J, Schooltink H, Stoyan T, Günther M, Graeve L, Buse G, Mackiewicz A, Heinrich P C, Rose-John S. 1993. The soluble IL-6 receptor is generated by shedding. Eur. J. Immunol. 23: 473.
33. Rose-John S, Heinrich P C. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. (Review) Biochem. J. 300: 281.
34. Ingham K C, Brew S A, Huff S, Litvinovitch S V. 1997. Cryptic self-association sites in type III modules of fibronectin. J. Biol. Chem. 272: 1718.
35. Rathjen P D, Toth S, Willis A, Heath J K, Smith A G. 1990. Differentiation inhibiting activity is produced in matrix-associated and diffusible forms generated by alternate promoter usage. Cell 62: 1105.
36. Chrousos G P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. (Review) N. Engl. J. Med. 332: 1351.